Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

Recruiting now · Phase 4

Conditions studied: Postoperative Complications, Respiratory Depression, Postoperative Nausea, Vomiting, Constipation

In brief

This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.

Key facts

Study ID

NCT06777758

Run by

Kaohsiung Veterans General Hospital.

People needed

90

Starts

2025-02-12

Expected to finish

2026-12-31

Last updated by the study team

2025-05-08

Who can join

Age: 20 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects are between 20-80 years old.
• Anesthesiologists rated ASA as between I and III.
• Patients undergoing upper gastrointestinal endoscopic examination or therapy.

You may not qualify if…

• Allergy to Propofol, Remimazolam, or opioid medications.
• Emergency surgery.
• Pregnancy.
• History of malignant hyperthermia.
• Impaired liver or kidney function.
• Airway difficulties due to pharyngeal tumors.
• Refusal to participate.

Where it is running

• Kaohsiung Veterans General Hospital — Kaohsiung City, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.